Bioactive lignan derivatives from the stems of Firmiana simplex
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woo, Kyeong Wan | - |
dc.contributor.author | Suh, Won Se | - |
dc.contributor.author | Subedi, Lalita | - |
dc.contributor.author | Kim, Sun Yeou | - |
dc.contributor.author | Kim, Aejung | - |
dc.contributor.author | Lee, Kang Ro | - |
dc.date.available | 2020-02-28T02:45:25Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-02-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8576 | - |
dc.description.abstract | The CHCl3 soluble fraction of the 80% MeOH extract of the stems of Firmiana simplex strongly inhibited nitric oxide production in lipopolysaccharide-activated BV-2 cells. A bioactivity-guided column chromatographic separation yielded two new lignans, firmianols A and B (1-2) together with seventeen known lignans (3-19). The structural elucidation of the new compounds was determined by spectroscopic methods, including 1D, 2D NMR and HR-FAB-MS. All isolated lignans were evaluated for their antineuroinflammatory effects on nitric oxide (NO) production in lipopolysaccharides (LPS)-activated murine microglia BV2 cells. Among the isolated, compounds 14 and 15 showed potent inhibitory activity against NO production (IC50 1.05 and 0.929 mu M, respectively) without cell toxicity in murine microglia BV-2 cells. Compounds 11-13 and 17 also exhibited strong inhibitory effects on NO production, with IC50 values ranging from 7.07 to 15.28 mu M. (C) 2016 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.subject | CHEMICAL-CONSTITUENTS | - |
dc.subject | INHIBITORY-ACTIVITY | - |
dc.subject | AERIAL PARTS | - |
dc.subject | NEOLIGNANS | - |
dc.subject | GLYCOSIDES | - |
dc.subject | MICROGLIA | - |
dc.subject | ETHER | - |
dc.subject | CELLS | - |
dc.subject | ROOT | - |
dc.title | Bioactive lignan derivatives from the stems of Firmiana simplex | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000368797600005 | - |
dc.identifier.doi | 10.1016/j.bmcl.2016.01.008 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.26, no.3, pp.730 - 733 | - |
dc.citation.endPage | 733 | - |
dc.citation.startPage | 730 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 26 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Subedi, Lalita | - |
dc.contributor.affiliatedAuthor | Kim, Sun Yeou | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Firmiana simplex | - |
dc.subject.keywordAuthor | Sterculiaceae | - |
dc.subject.keywordAuthor | Lignan | - |
dc.subject.keywordAuthor | Anti-neuroinflammatory effect | - |
dc.subject.keywordPlus | CHEMICAL-CONSTITUENTS | - |
dc.subject.keywordPlus | INHIBITORY-ACTIVITY | - |
dc.subject.keywordPlus | AERIAL PARTS | - |
dc.subject.keywordPlus | NEOLIGNANS | - |
dc.subject.keywordPlus | GLYCOSIDES | - |
dc.subject.keywordPlus | MICROGLIA | - |
dc.subject.keywordPlus | ETHER | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | ROOT | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.